Cargando…

Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties

BACKGROUND: Intravitreal injection (IVI) of antibody biologics is a key treatment approach in ophthalmology. Pharmaceutical compounding and storage of prefilled syringes for IVI must take place without impairing the structure and function of the biologics. This study investigated the effect of withd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jørstad, Øystein Kalsnes, Foss, Stian, Gjølberg, Torleif Tollefsrud, Mester, Simone, Nyquist-Andersen, Mari, Sivertsen, Magne Sand, Fossum, Dag, Gleditsch, Espen, Moe, Morten Carstens, Andersen, Jan Terje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631190/ https://www.ncbi.nlm.nih.gov/pubmed/37936232 http://dx.doi.org/10.1186/s40942-023-00507-3

Ejemplares similares

A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes
por: Lode, Heidrun Elisabeth, et al.
Publicado: (2019)

Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study
por: Sivertsen, Magne Sand, et al.
Publicado: (2021)

Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties
por: Sivertsen, Magne Sand, et al.
Publicado: (2018)

Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
por: Gjølberg, Torleif Tollefsrud, et al.
Publicado: (2022)

Mask use by patients in the context of COVID‐19 can increase the risk of postinjection endophthalmitis
por: Blom, Kathrine, et al.
Publicado: (2021)

Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema
por: Hertzberg, Silvia NW, et al.
Publicado: (2022)

Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study
por: Jelin, Elma, et al.
Publicado: (2019)

Antibody blockade of Jagged1 attenuates choroidal neovascularization
por: Gjølberg, Torleif Tollefsrud, et al.
Publicado: (2023)

Loss of horizontal macular ganglion cell complex asymmetry: an optical coherence tomography indicator of chiasmal compression
por: Jørstad, Øystein Kalsnes, et al.
Publicado: (2018)

Acute macular neuroretinopathy following COVID-19 vaccination
por: Bøhler, Anders Djupesland, et al.
Publicado: (2021)

Retinal injuries in seven teenage boys from the same handheld laser
por: Faraj, Sayed, et al.
Publicado: (2022)

A Pilot Study of Implementing Diabetic Retinopathy Screening in the Oslo Region, Norway: Baseline Results
por: Sauesund, Ellen Steffenssen, et al.
Publicado: (2023)

Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases
por: Christopoulos, Panagiotis F., et al.
Publicado: (2021)

Multiple Vitelliform Lesions as a Retinal Manifestation of Alport Syndrome
por: Eriksen, Kathrine O., et al.
Publicado: (2020)

Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
por: Rush, Ryan B, et al.
Publicado: (2022)

Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
por: Kusuhara, Sentaro, et al.
Publicado: (2023)

Turnover of Microaneurysms After Intravitreal Injections of Faricimab for Diabetic Macular Edema
por: Takamura, Yoshihiro, et al.
Publicado: (2023)

A Multi-Lumen Glaucoma Stent With Titratable Pressure-Lowering Effect: A Proof of Concept Study
por: Sverstad, Alexander, et al.
Publicado: (2022)

In Vivo Evidence for Impaired Glymphatic Function in the Visual Pathway of Patients With Normal Pressure Hydrocephalus
por: Jacobsen, Henrik Holvin, et al.
Publicado: (2020)

Faricimab for Treatment-Resistant Diabetic Macular Edema
por: Rush, Ryan B, et al.
Publicado: (2022)

Noninvasive Estimation of Pulsatile and Static Intracranial Pressure by Optical Coherence Tomography
por: Jacobsen, Henrik Holvin, et al.
Publicado: (2022)

The acute phase response protein SERPINA3 is increased in tear fluid from the unaffected eyes of patients with unilateral acute anterior uveitis
por: Eidet, Jon Roger, et al.
Publicado: (2021)

Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life
por: Grevys, Algirdas, et al.
Publicado: (2022)

TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity
por: Foss, Stian, et al.
Publicado: (2015)

National application of the European visual field standards for driving: a survey study
por: Sudmann, Thea Melsen, et al.
Publicado: (2022)

Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis: A prospective observational study
por: Blom, Kathrine, et al.
Publicado: (2022)

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
por: Ohara, Hiromi, et al.
Publicado: (2023)

TRIM21—From Intracellular Immunity to Therapy
por: Foss, Stian, et al.
Publicado: (2019)

Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare Perspective
por: Hertzberg, Silvia Nanjala Walekhwa, et al.
Publicado: (2022)

One Year Results of Faricimab for Aflibercept-Resistant Diabetic Macular Edema
por: Rush, Ryan B
Publicado: (2023)

Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
por: Tamiya, Ryosuke, et al.
Publicado: (2023)

Unilateral acute anterior uveitis is associated with ipsilateral changes in the tear fluid proteome that involves the LXR/RXR pathway
por: Eidet, Jon Roger, et al.
Publicado: (2020)

Old Problem in a New Guise: Retinal Pigment Epithelium Tear after Intravitreal Faricimab (Vabysmo(®)) Injection
por: Clemens, Christoph R., et al.
Publicado: (2023)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2023)

Fusion of engineered albumin with factor IX Padua extends half‐life and improves coagulant activity
por: Lombardi, Silvia, et al.
Publicado: (2021)

Machine Learning to Predict Faricimab Treatment Outcome in Neovascular Age-Related Macular Degeneration
por: Kikuchi, Yusuke, et al.
Publicado: (2023)

Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies
por: Panos, Georgios D, et al.
Publicado: (2023)

Prefilled syringes for intravitreal drug delivery
por: Sassalos, Thérèse M, et al.
Publicado: (2019)

Antibody-antigen kinetics constrain intracellular humoral immunity
por: Bottermann, Maria, et al.
Publicado: (2016)

Corrigendum: Antibody-antigen kinetics constrain intracellular humoral immunity
por: Bottermann, Maria, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_08s8mg7ual3t7100r7etaspt70